On the public citation graph

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)

0 signed · 287 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/hep.20935openalex-snapshot

A novel panel of blood markers to assess the degree of liver fibrosis†

inferredcites →https://doi.org/10.1002/hep.21178openalex-snapshot

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

inferredcites →https://doi.org/10.1002/hep.21496openalex-snapshot

The NAFLD fibrosis score

inferredcites →https://doi.org/10.1002/hep.23050openalex-snapshot

Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis

inferredcites →https://doi.org/10.1002/hep.24356openalex-snapshot

Fatty liver index and mortality: The cremona study in the 15th year of follow-up

inferredcites →https://doi.org/10.1002/hep.24706openalex-snapshot

Serum Ferritin Is An Independent Predictor of Histologic Severity and Advanced Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

inferredcites →https://doi.org/10.1002/hep.26030openalex-snapshot

Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease

inferredcites →https://doi.org/10.1002/hep.26156openalex-snapshot

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

inferredcites →https://doi.org/10.1002/hep.26238openalex-snapshot

Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease

inferredcites →https://doi.org/10.1002/hep.27173openalex-snapshot

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease

inferredcites →https://doi.org/10.1002/hep.27368openalex-snapshot

Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

inferredcites →https://doi.org/10.1002/hep.28431openalex-snapshot

Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes

inferredcites →https://doi.org/10.1002/hep.28776openalex-snapshot

Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease

inferredcites →https://doi.org/10.1002/hep.29179openalex-snapshot

Assessment of biopsy‐proven liver fibrosis by two‐dimensional shear wave elastography: An individual patient data‐based meta‐analysis

inferredcites →https://doi.org/10.1002/hep.29197openalex-snapshot

How to identify patients with advanced liver disease in the community?

inferredcites →https://doi.org/10.1002/hep.29367openalex-snapshot

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

inferredcites →https://doi.org/10.1002/hep.29466openalex-snapshot

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

inferredcites →https://doi.org/10.1002/hep.29797openalex-snapshot

Noninvasive, Quantitative Assessment of Liver Fat by MRI‐PDFF as an Endpoint in NASH Trials

inferredcites →https://doi.org/10.1002/hep.510240410openalex-snapshot

Clinical Hepatology: Profile of An Urban, Hospital–Based Practic

inferredcites →https://doi.org/10.1002/jmri.23741openalex-snapshot

Proton density fat‐fraction: A standardized mr‐based biomarker of tissue fat concentration

inferredcites →https://doi.org/10.1002/lt.25303openalex-snapshot

Liver Transplantation and Bariatric Surgery: Timing and Outcomes

inferredcites →https://doi.org/10.1002/mrm.25681openalex-snapshot

Sensitivity of chemical shift‐encoded fat quantification to calibration of fat MR spectrum

inferredcites →https://doi.org/10.1007/s10620-017-4684-xopenalex-snapshot

Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes

inferredcites →https://doi.org/10.1007/s11901-018-0421-yopenalex-snapshot

The Role of Radiologic Modalities in Diagnosing Nonalcoholic Steatohepatitis (NASH) and Fibrosis

inferredcites →https://doi.org/10.1016/0016-5085(90)91167-5openalex-snapshot

A 21-year experience with major hemorrhage after percutaneous liver biopsy

inferredcites →https://doi.org/10.1016/bs.apha.2019.01.003openalex-snapshot

Drug-induced liver injury in obesity and nonalcoholic fatty liver disease

inferredcites →https://doi.org/10.1016/j.anndiagpath.2018.09.009openalex-snapshot

Nonalcoholic fatty liver disease (NAFLD): Diagnosis, pitfalls, and staging

inferredcites →https://doi.org/10.1016/j.bbalip.2013.12.006openalex-snapshot

Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function

inferredcites →https://doi.org/10.1016/j.cgh.2014.09.046openalex-snapshot

Diagnostic Performance of Magnetic Resonance Elastography in Staging Liver Fibrosis: A Systematic Review and Meta-analysis of Individual Participant Data

inferredcites →https://doi.org/10.1016/j.cgh.2016.08.028openalex-snapshot

Nonobese Fatty Liver Disease

inferredcites →https://doi.org/10.1016/j.cgh.2017.12.001openalex-snapshot

Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes

inferredcites →https://doi.org/10.1016/j.cld.2009.07.006openalex-snapshot

Lifestyle Modification as the Primary Treatment of NASH

inferredcites →https://doi.org/10.1016/j.clinre.2019.01.001openalex-snapshot

Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions

inferredcites →https://doi.org/10.1016/j.dld.2009.08.002openalex-snapshot

Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease

inferredcites →https://doi.org/10.1016/j.ejrad.2017.08.029openalex-snapshot

Liver investigations: Updating on US technique and contrast-enhanced ultrasound (CEUS)

inferredcites →https://doi.org/10.1016/j.ejrad.2017.11.003openalex-snapshot

MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease

inferredcites →https://doi.org/10.1016/j.freeradbiomed.2015.12.014openalex-snapshot

Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development

inferredcites →https://doi.org/10.1016/j.jceh.2012.10.010openalex-snapshot

A Randomized Controlled Trial Comparing Efficacy of Pentoxifylline and Pioglitazone on Metabolic Factors and Liver Histology in Patients with Non-alcoholic Steatohepatitis

inferredcites →https://doi.org/10.1016/j.jcmgh.2015.05.006openalex-snapshot

Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences

inferredcites →https://doi.org/10.1016/j.jhep.2010.04.008openalex-snapshot

A position statement on NAFLD/NASH based on the EASL 2009 special conference

inferredcites →https://doi.org/10.1016/j.jhep.2010.05.018openalex-snapshot

Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride

inferredcites →https://doi.org/10.1016/j.jhep.2010.08.023openalex-snapshot

An apoptosis panel for nonalcoholic steatohepatitis diagnosis

inferredcites →https://doi.org/10.1016/j.jhep.2010.12.019openalex-snapshot

Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease

inferredcites →https://doi.org/10.1016/j.jhep.2012.12.021openalex-snapshot

Liver fibrosis evaluation using real-time shear wave elastography: Applicability and diagnostic performance using methods without a gold standard

inferredcites →https://doi.org/10.1016/j.jhep.2013.03.028openalex-snapshot

Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases

inferredcites →https://doi.org/10.1016/j.jhep.2013.12.026openalex-snapshot

Biomarkers of liver cell death

inferredcites →https://doi.org/10.1016/j.jhep.2014.10.042openalex-snapshot

An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: The Liver-FibroSTARD standards

inferredcites →https://doi.org/10.1016/j.jhep.2015.11.004openalex-snapshot

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

inferredcites →https://doi.org/10.1016/j.jhep.2016.03.004openalex-snapshot

Exosomes in liver pathology

inferredcites →https://doi.org/10.1016/j.jhep.2017.02.014openalex-snapshot

Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD

inferredcites →https://doi.org/10.1016/j.jhep.2017.09.003openalex-snapshot

Genetics and epigenetics of NAFLD and NASH: Clinical impact

inferredcites →https://doi.org/10.1016/j.jhep.2017.11.026openalex-snapshot

The molecular functions of hepatocyte nuclear factors – In and beyond the liver

inferredcites →https://doi.org/10.1016/j.jhep.2018.05.036openalex-snapshot

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

inferredcites →https://doi.org/10.1016/j.jhep.2019.04.020openalex-snapshot

New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD

inferredcites →https://doi.org/10.1016/j.livres.2018.01.001openalex-snapshot

Extracellular vesicles in non-alcoholic and alcoholic fatty liver diseases

inferredcites →https://doi.org/10.1016/j.metabol.2015.12.012openalex-snapshot

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

inferredcites →https://doi.org/10.1016/j.soard.2019.05.004openalex-snapshot

Validation of biochemical scores for liver steatosis before and 1 year after sleeve gastrectomy

inferredcites →https://doi.org/10.1016/j.ultrasmedbio.2010.07.005openalex-snapshot

Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes

inferredcites →https://doi.org/10.1016/s0016-5085(17)30587-5openalex-snapshot

Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease

inferredcites →https://doi.org/10.1016/s0140-6736(14)61933-4openalex-snapshot

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

inferredcites →https://doi.org/10.1016/s0168-8278(98)80073-1openalex-snapshot

Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance

inferredcites →https://doi.org/10.1016/s2468-1253(16)30011-5openalex-snapshot

Pathogenesis and novel treatment options for non-alcoholic steatohepatitis

inferredcites →https://doi.org/10.1038/ajg.2010.170openalex-snapshot

A Role for Low Hepatic Copper Concentrations in Nonalcoholic Fatty Liver Disease

inferredcites →https://doi.org/10.1038/ajg.2016.65openalex-snapshot

Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study

inferredcites →https://doi.org/10.1038/ng.257openalex-snapshot

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

inferredcites →https://doi.org/10.1038/nrdp.2015.80openalex-snapshot

Nonalcoholic fatty liver disease

inferredcites →https://doi.org/10.1038/s41575-018-0014-9openalex-snapshot

Noninvasive biomarkers in NAFLD and NASH — current progress and future promise

inferredcites →https://doi.org/10.1038/s41591-018-0104-9openalex-snapshot

Mechanisms of NAFLD development and therapeutic strategies

inferredcites →https://doi.org/10.1038/s41598-017-03389-2openalex-snapshot

Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells

inferredcites →https://doi.org/10.1038/s41598-017-04991-0openalex-snapshot

MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals

inferredcites →https://doi.org/10.1038/s41598-017-05257-5openalex-snapshot

Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease

inferredcites →https://doi.org/10.1053/j.gastro.2004.08.052openalex-snapshot

Serum markers detect the presence of liver fibrosis: A cohort study

inferredcites →https://doi.org/10.1053/j.gastro.2005.03.084openalex-snapshot

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

inferredcites →https://doi.org/10.1053/j.gastro.2009.06.005openalex-snapshot

Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors

inferredcites →https://doi.org/10.1053/j.gastro.2010.09.038openalex-snapshot

Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

inferredcites →https://doi.org/10.1053/j.gastro.2015.04.043openalex-snapshot

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

inferredcites →https://doi.org/10.1053/j.gastro.2015.11.048openalex-snapshot

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography

inferredcites →https://doi.org/10.1053/j.gastro.2016.10.026openalex-snapshot

Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease

inferredcites →https://doi.org/10.1053/j.gastro.2018.12.036openalex-snapshot

Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease

inferredcites →https://doi.org/10.1055/s-0038-1677517openalex-snapshot

NASH in Lean Individuals

inferredcites →https://doi.org/10.1055/s-0039-1679920openalex-snapshot

Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics

inferredcites →https://doi.org/10.1055/s-0039-1687851openalex-snapshot

Macrophages as Key Players during Adipose Tissue–Liver Crosstalk in Nonalcoholic Fatty Liver Disease

inferredcites →https://doi.org/10.1074/jbc.ra119.008778openalex-snapshot

Liver-specific deletion of IGF2 mRNA binding protein-2/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation

inferredcites →https://doi.org/10.1080/00365521.2017.1379556openalex-snapshot

IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD – a pilot study

inferredcites →https://doi.org/10.1080/17474124.2018.1530110openalex-snapshot

An update on the recent advances in antifibrotic therapy

inferredcites →https://doi.org/10.1093/bmb/ldw031openalex-snapshot

Non-alcoholic fatty liver disease in 2016

inferredcites →https://doi.org/10.1093/hmg/ddp357openalex-snapshot

The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver

inferredcites →https://doi.org/10.1097/mcg.0000000000001229openalex-snapshot

Increasing Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease Among Hospitalized Adults in the United States

inferredcites →https://doi.org/10.1097/meg.0000000000001033openalex-snapshot

Impact of steatosis and inflammation definitions on the performance of NASH tests

inferredcites →https://doi.org/10.1097/tp.0000000000002484openalex-snapshot

Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation

inferredcites →https://doi.org/10.1109/58.996560openalex-snapshot

Shear modulus imaging with 2-D transient elastography

inferredcites →https://doi.org/10.1109/tuffc.2004.1295425openalex-snapshot

Supersonic shear imaging: a new technique for soft tissue elasticity mapping

inferredcites →https://doi.org/10.1111/apt.12569openalex-snapshot

Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin‐18 fragments

inferredcites →https://doi.org/10.1111/apt.14172openalex-snapshot

Laboratory parameter‐based machine learning model for excluding non‐alcoholic fatty liver disease ( NAFLD ) in the general population

inferredcites →https://doi.org/10.1111/apt.15314openalex-snapshot

Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications

inferredcites →https://doi.org/10.1111/j.1365-2036.2007.03586.xopenalex-snapshot

Adipokines and cytokines in non‐alcoholic fatty liver disease

inferredcites →https://doi.org/10.1111/j.1365-2362.2010.02338.xopenalex-snapshot

Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease

inferredcites →https://doi.org/10.1111/j.1440-1746.2008.05731.xopenalex-snapshot

The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease

inferredcites →https://doi.org/10.1111/j.1478-3231.2006.01312.xopenalex-snapshot

Non‐invasive markers to predict the liver fibrosis in non‐alcoholic fatty liver disease

inferredcites →https://doi.org/10.1111/j.1478-3231.2008.01691.xopenalex-snapshot

Utilization rates, complications and costs of percutaneous liver biopsy: a population‐based study including 4275 biopsies

inferredcites →https://doi.org/10.1111/j.1572-0241.2007.01520.xopenalex-snapshot

Abdominal Ultrasound for Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD)

inferredcites →https://doi.org/10.1111/j.1753-4887.2007.tb00329.xopenalex-snapshot

Obesity and Nonalcoholic Fatty Liver Disease

inferredcites →https://doi.org/10.1111/jgh.14104openalex-snapshot

Prediction of carotid intima–media thickness in obese patients with low prevalence of comorbidities by serum copper bioavailability

inferredcites →https://doi.org/10.1111/liv.12024openalex-snapshot

Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease

inferredcites →https://doi.org/10.1111/liv.13441openalex-snapshot

The transformation in biomarker detection and management of drug‐induced liver injury

inferredcites →https://doi.org/10.1111/liv.14084openalex-snapshot

MACK‐3 (combination of hoMa, Ast and CK18): A promising novel biomarker for fibrotic non‐alcoholic steatohepatitis

inferredcites →https://doi.org/10.1136/bmjopen-2018-023597openalex-snapshot

Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study

inferredcites →https://doi.org/10.1136/gut.2007.146019openalex-snapshot

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease

inferredcites →https://doi.org/10.1136/gut.2010.216077openalex-snapshot

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

inferredcites →https://doi.org/10.1146/annurev-physiol-021115-105331openalex-snapshot

Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease

inferredcites →https://doi.org/10.1148/radiol.2017162931openalex-snapshot

MR Spectroscopy–derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis

inferredcites →https://doi.org/10.1148/radiology.141.1.6270725openalex-snapshot

Ultrasonography of alcoholic liver disease with histological correlation.

inferredcites →https://doi.org/10.1152/ajpgi.00521.2005openalex-snapshot

Lipid Metabolism and Liver Inflammation. II. Fatty liver disease and fatty acid oxidation

inferredcites →https://doi.org/10.1155/2015/815721openalex-snapshot

OSAS‐Related Inflammatory Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease

inferredcites →https://doi.org/10.1155/2017/9729107openalex-snapshot

Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

inferredcites →https://doi.org/10.1159/000439083openalex-snapshot

Tissue Inhibitors of Metalloproteinase-1 and 2 and Obesity Related Non-Alcoholic Fatty Liver Disease: Is There a Relationship?

inferredcites →https://doi.org/10.1177/1756283x11430859openalex-snapshot

Secondary causes of nonalcoholic fatty liver disease

inferredcites →https://doi.org/10.1186/1471-230x-10-98openalex-snapshot

A simple index of lipid overaccumulation is a good marker of liver steatosis

inferredcites →https://doi.org/10.1186/1471-230x-6-33openalex-snapshot

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

inferredcites →https://doi.org/10.1186/1471-230x-6-34openalex-snapshot

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

inferredcites →https://doi.org/10.1186/s12864-018-4575-3openalex-snapshot

A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis

inferredcites →https://doi.org/10.1186/s12916-014-0154-xopenalex-snapshot

Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA

inferredcites →https://doi.org/10.1194/jlr.m007096openalex-snapshot

Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

inferredcites →https://doi.org/10.1301/nr.2007.jun.s57-s63openalex-snapshot

Obesity and Nonalcoholic Fatty Liver Disease

inferredcites →https://doi.org/10.1371/journal.pone.0024895openalex-snapshot

Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study

inferredcites →https://doi.org/10.1371/journal.pone.0030014openalex-snapshot

Foxa1 Reduces Lipid Accumulation in Human Hepatocytes and Is Down-Regulated in Nonalcoholic Fatty Liver

inferredcites →https://doi.org/10.1371/journal.pone.0141649openalex-snapshot

Evaluation of Transient Elastography, Acoustic Radiation Force Impulse Imaging (ARFI), and Enhanced Liver Function (ELF) Score for Detection of Fibrosis in Morbidly Obese Patients

inferredcites →https://doi.org/10.1371/journal.pone.0173992openalex-snapshot

High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal

inferredcites →https://doi.org/10.1371/journal.pone.0190993openalex-snapshot

The obesity epidemic and rising diabetes incidence in a low-income racially diverse southern US cohort

inferredcites →https://doi.org/10.1371/journal.pone.0214436openalex-snapshot

Non-invasive assessment of NAFLD as systemic disease—A machine learning perspective

inferredcites →https://doi.org/10.1373/clinchem.2005.048389openalex-snapshot

Hepascore: An Accurate Validated Predictor of Liver Fibrosis in Chronic Hepatitis C Infection

inferredcites →https://doi.org/10.14218/jcth.2017.00009openalex-snapshot

Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease

inferredcites →https://doi.org/10.1515/cclm-2015-0241openalex-snapshot

Liver-FibroSTARD checklist and glossary: tools for standardized design and reporting of diagnostic accuracy studies of liver fibrosis tests

inferredcites →https://doi.org/10.15252/emmm.201809302openalex-snapshot

The role of the microbiome in NAFLD and NASH

inferredcites →https://doi.org/10.1530/ec-13-0040openalex-snapshot

Increased FGF21 plasma levels in humans with sepsis and SIRS

inferredcites →https://doi.org/10.1530/eje-16-1063openalex-snapshot

MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease

inferredcites →https://doi.org/10.1586/14737159.5.1.15openalex-snapshot

FibroTest-FibroSURE™: towards a universal biomarker of liver fibrosis?

inferredcites →https://doi.org/10.1590/s0100-879x2005000500012openalex-snapshot

Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease

inferredcites →https://doi.org/10.3389/fimmu.2019.02852openalex-snapshot

Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases

inferredcites →https://doi.org/10.3389/fphar.2016.00283openalex-snapshot

Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury

inferredcites →https://doi.org/10.3389/fphar.2018.00805openalex-snapshot

A General Overview on Non-coding RNA-Based Diagnostic and Therapeutic Approaches for Liver Diseases

inferredcites →https://doi.org/10.3389/fphys.2018.01256openalex-snapshot

Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders

inferredcites →https://doi.org/10.3390/antiox8110524openalex-snapshot

White Peony (Fermented Camellia sinensis) Polyphenols Help Prevent Alcoholic Liver Injury via Antioxidation

inferredcites →https://doi.org/10.3390/biomedicines6040106openalex-snapshot

Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects

inferredcites →https://doi.org/10.3390/cells9051105openalex-snapshot

Special Issue on “Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis”

inferredcites →https://doi.org/10.3390/cells9051237openalex-snapshot

Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH

inferredcites →https://doi.org/10.3390/ijms19010261openalex-snapshot

The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity

inferredcites →https://doi.org/10.3390/ijms19072034openalex-snapshot

New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis

inferredcites →https://doi.org/10.3390/ijms19123715openalex-snapshot

Liver-Derived Exosomes and Their Implications in Liver Pathobiology

inferredcites →https://doi.org/10.3390/medicina55050166openalex-snapshot

Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease

inferredcites →https://doi.org/10.3390/microorganisms7110530openalex-snapshot

Isolation and Identification of Lactobacillus plantarum HFY05 from Natural Fermented Yak Yogurt and Its Effect on Alcoholic Liver Injury in Mice

inferredcites →https://doi.org/10.3748/wjg.v24.i30.3361openalex-snapshot

Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis

inferredcites →https://doi.org/10.4103/jmu.jmu_53_18openalex-snapshot

Correlational Study of Nonalcoholic Fatty Liver Disease Diagnosed by Ultrasonography with Lipid Profile and Body Mass Index in Adult Nepalese Population

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4481966openalex-extracted

Artificial Intelligence in Identifying Patients with Undiagnosed Nonalcoholic Steatohepatitis

inferred← citeshttps://doi.org/10.1002/ajum.12244openalex-snapshot

Performance of shear wave elastography: A single centre pilot study of mixed etiology liver disease patients with normal BMI

inferred← citeshttps://doi.org/10.1002/cbdv.202100243openalex-snapshot

Effect of Compounds from Moringa oleifera Lam. on in Vitro Non‐Alcoholic Fatty Liver Disease (NAFLD) Model System

inferred← citeshttps://doi.org/10.1002/dmrr.3386openalex-snapshot

NAFLD in type 2 diabetes mellitus: Still many challenging questions

inferred← citeshttps://doi.org/10.1002/fsn3.4010openalex-snapshot

Silymarin: Unveiling its pharmacological spectrum and therapeutic potential in liver diseases—A comprehensive narrative review

inferred← citeshttps://doi.org/10.1002/fsn3.70073openalex-snapshot

Resveratrol Relieves Hepatic Steatosis and Enhances the Effects of Atorvastatin in a Mouse Model of NAFLD by Regulating the Renin‐Angiotensin System, Oxidative Stress, and Inflammation

inferred← citeshttps://doi.org/10.1002/ijc.34637openalex-snapshot

Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients

inferred← citeshttps://doi.org/10.1002/widm.70044openalex-snapshot

Automated Detection of Non‐Alcoholic Fatty Liver Disease Using Histopathological Images: A Systematic Review

inferred← citeshttps://doi.org/10.1007/978-3-030-53370-0_24openalex-snapshot

Non-alcoholic Fatty Liver Disease: A Global Public Health Issue

inferred← citeshttps://doi.org/10.1007/978-3-030-84164-5_16openalex-snapshot

Delivery of Oligonucleotide Therapeutics for Macrophage Reprogramming in Inflammatory Diseases

inferred← citeshttps://doi.org/10.1007/978-981-95-8946-3_4openalex-snapshot

Non-healing Foot Ulcers in Diabetes: Challenges in Wound Healing and Strategies For Limb Preservation

inferred← citeshttps://doi.org/10.1007/s00125-024-06224-2openalex-snapshot

Zinc finger BED-type containing 3 promotes hepatic steatosis by interacting with polypyrimidine tract-binding protein 1

inferred← citeshttps://doi.org/10.1007/s00330-024-11119-2openalex-snapshot

Comparing ultrasound-derived fat fraction and MRI-PDFF for quantifying hepatic steatosis: a real-world prospective study

inferred← citeshttps://doi.org/10.1007/s10142-025-01720-zopenalex-snapshot

C6ORF120 regulates hepatic lipid metabolism through PPAR signaling pathway in metabolic dysfunction-associated steatotic liver disease

inferred← citeshttps://doi.org/10.1007/s10353-020-00685-6openalex-snapshot

Liver resections for colorectal liver metastases in elderly patients

inferred← citeshttps://doi.org/10.1007/s11695-024-07376-1openalex-snapshot

Effect of Bariatric Surgery on the Sonographic Grade of Metabolic-Associated Fatty Liver Disease at 12-Month Follow-Up

inferred← citeshttps://doi.org/10.1007/s11901-021-00577-7openalex-snapshot

Screening for Non-alcoholic Fatty Liver Disease in Current Practice

inferred← citeshttps://doi.org/10.1007/s12072-026-11112-5openalex-snapshot

Alcohol consumption and dementia risk in steatotic liver disease: a nationwide cohort study

inferred← citeshttps://doi.org/10.1007/s12602-026-11050-6openalex-snapshot

The Gut-Liver Axis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Mechanisms, Microbiome Interactions and Therapeutic Targets

inferred← citeshttps://doi.org/10.1007/s13748-025-00387-8openalex-snapshot

On the role of explanations in machine learning prediction of nonalcoholic steatohepatitis

inferred← citeshttps://doi.org/10.1007/s40291-021-00544-4openalex-snapshot

Milestones of Precision Medicine: An Innovative, Multidisciplinary Overview

inferred← citeshttps://doi.org/10.1016/j.aanat.2020.151626openalex-snapshot

Can Dasatinib Ameliorate the Hepatic changes, Induced by Long Term Western Diet, in Mice?

inferred← citeshttps://doi.org/10.1016/j.actbio.2024.06.014openalex-snapshot

Nanoformulations for the diagnosis and treatment of metabolic dysfunction-associated steatohepatitis

inferred← citeshttps://doi.org/10.1016/j.artmed.2025.103223openalex-snapshot

Identifying signatures of image phenotypes to track treatment response in liver disease

inferred← citeshttps://doi.org/10.1016/j.bbrc.2020.06.126openalex-snapshot

Secreted phosphoglucose isomerase is a novel biomarker of nonalcoholic fatty liver in mice and humans

inferred← citeshttps://doi.org/10.1016/j.bbrc.2021.01.002openalex-snapshot

Hypoxia-inducible factor-2 promotes liver fibrosis in non-alcoholic steatohepatitis liver disease via the NF-κB signalling pathway

inferred← citeshttps://doi.org/10.1016/j.cct.2020.106170openalex-snapshot

A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study

inferred← citeshttps://doi.org/10.1016/j.cej.2020.127125openalex-snapshot

High-pressure homogenization and tailoring of size-tunable Ganoderma lucidum spore oil nanosystem for enhanced anticancer therapy

inferred← citeshttps://doi.org/10.1016/j.ejim.2025.07.014openalex-snapshot

sTREM2 evaluation in women with metabolic dysfunction-associated steatotic liver disease: Advancing diagnostic approaches for early MASH

inferred← citeshttps://doi.org/10.1016/j.ejphar.2020.172913openalex-snapshot

Challenges and opportunities in drug development for nonalcoholic steatohepatitis

inferred← citeshttps://doi.org/10.1016/j.gastre.2023.07.006openalex-snapshot

Vinpocetine represses the progression of nonalcoholic steatohepatitis in mice by mediating inflammasome components via NF-κB signaling

inferred← citeshttps://doi.org/10.1016/j.gastrohep.2023.07.006openalex-snapshot

Vinpocetine represses the progression of nonalcoholic steatohepatitis in mice by mediating inflammasome components via NF-κB signaling

inferred← citeshttps://doi.org/10.1016/j.heliyon.2022.e11119openalex-snapshot

Deciphering the role of aberrant DNA methylation in NAFLD and NASH

inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e28468openalex-snapshot

Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.141660openalex-snapshot

Targeting regulation of lipid metabolism with polysaccharide of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease: A review

inferred← citeshttps://doi.org/10.1016/j.intimp.2021.108503openalex-snapshot

Dapagliflozin improves steatohepatitis in diabetic rats via inhibition of oxidative stress and inflammation

inferred← citeshttps://doi.org/10.1016/j.jchromb.2025.124784openalex-snapshot

Quyu Huazhuo Decoction alleviates non-Alcoholic steatohepatitis via remodeling the gut microbiota and regulating bile acid and short-chain fatty acid metabolism

inferred← citeshttps://doi.org/10.1016/j.jff.2019.103726openalex-snapshot

Açaí (Euterpe oleracea Mart.) seed extract protects against hepatic steatosis and fibrosis in high-fat diet-fed mice: Role of local renin-angiotensin system, oxidative stress and inflammation

inferred← citeshttps://doi.org/10.1016/j.jnutbio.2021.108602openalex-snapshot

Tomatidine ameliorates obesity-induced nonalcoholic fatty liver disease in mice

inferred← citeshttps://doi.org/10.1016/j.lfs.2023.121894openalex-snapshot

Therapeutic implications of targeting autophagy and TGF-β crosstalk for the treatment of liver fibrosis

inferred← citeshttps://doi.org/10.1016/j.livres.2025.10.005openalex-snapshot

Metabolites involvement in the growth and spread of liver cancer

inferred← citeshttps://doi.org/10.1016/j.metabol.2020.154218openalex-snapshot

New American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) guidelines for the pharmacotherapy of type 2 diabetes: Placing them into a practicing physician's perspective

inferred← citeshttps://doi.org/10.1016/j.obmed.2020.100243openalex-snapshot

Non Alcoholic Fatty Liver Disease and Degree of Steatosis in Diabetic and Non- Diabetic patients

inferred← citeshttps://doi.org/10.1016/j.phrs.2020.104684openalex-snapshot

Human antigen R: A potential therapeutic target for liver diseases

inferred← citeshttps://doi.org/10.1016/j.prp.2023.154809openalex-snapshot

A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression

inferred← citeshttps://doi.org/10.1016/j.saa.2020.118298openalex-snapshot

Physiological changes in the albumin-bound non-esterified free fatty acids critically influence heme/bilirubin binding properties of the protein: A comparative, in vitro, spectroscopic study using the endogenous biomolecules

inferred← citeshttps://doi.org/10.1016/j.tox.2020.152493openalex-snapshot

Mechanism-based identification of plasma metabolites associated with liver toxicity

inferred← citeshttps://doi.org/10.1016/j.tox.2021.153021openalex-snapshot

MCLR-elicited hepatic fibrosis and carcinogenic gene expression changes persist in rats with diet-induced nonalcoholic steatohepatitis through a 4-week recovery period

inferred← citeshttps://doi.org/10.1016/j.ultrasmedbio.2024.09.019openalex-snapshot

Ex Vivo Demonstration of a Novel Dual-Frequency Ultrasound Method for Quantitative Measurements of Liver Fat Content

inferred← citeshttps://doi.org/10.1021/acsnano.2c06233openalex-snapshot

Myeloperoxidase-Sensitive T1 and T2 Switchable MR Imaging for Diagnosis of Nonalcoholic Steatohepatitis

inferred← citeshttps://doi.org/10.1038/s41366-020-00687-0openalex-snapshot

Modifications of IGF2 and EGFR plasma protein concentrations in NAFLD patients after bariatric surgery

inferred← citeshttps://doi.org/10.1038/s41390-021-01754-6openalex-snapshot

Predictors of non-alcoholic fatty liver disease in children

inferred← citeshttps://doi.org/10.1038/s41467-021-23285-8openalex-snapshot

PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling

inferred← citeshttps://doi.org/10.1038/s41598-020-75266-4openalex-snapshot

Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease

inferred← citeshttps://doi.org/10.1038/s41598-021-04361-xopenalex-snapshot

Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease

inferred← citeshttps://doi.org/10.1038/s41598-021-85421-0openalex-snapshot

Elevation of plasma tRNA fragments as a promising biomarker for liver fibrosis in nonalcoholic fatty liver disease

inferred← citeshttps://doi.org/10.1038/s41598-021-88733-3openalex-snapshot

Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease

inferred← citeshttps://doi.org/10.1038/s41598-022-07937-3openalex-snapshot

Clitorin ameliorates western diet-induced hepatic steatosis by regulating lipogenesis and fatty acid oxidation in vivo and in vitro

inferred← citeshttps://doi.org/10.1038/s41598-023-32551-2openalex-snapshot

NASHmap: clinical utility of a machine learning model to identify patients at risk of NASH in real-world settings

inferred← citeshttps://doi.org/10.1063/5.0081695openalex-snapshot

Development of resveratrol with thiolated alginate as a supplement to prevent nonalcoholic fatty liver disease (NAFLD)

inferred← citeshttps://doi.org/10.1080/17474124.2020.1801413openalex-snapshot

Noninvasive diagnostic tools for pediatric NAFLD: where are we now?

inferred← citeshttps://doi.org/10.1093/jn/nxaa410openalex-snapshot

Dietary Fruit and Vegetable Supplementation Suppresses Diet-Induced Atherosclerosis in LDL Receptor Knockout Mice

inferred← citeshttps://doi.org/10.1097/hep.0000000000000867openalex-snapshot

Novel proteomic signatures may indicate MRI-assessed intrahepatic fat state and changes: The DIRECT PLUS clinical trial

inferred← citeshttps://doi.org/10.1097/qad.0000000000003170openalex-snapshot

Prevalence of nonalcoholic fatty liver disease using noninvasive techniques among children, adolescents, and youths living with HIV

inferred← citeshttps://doi.org/10.1111/1753-0407.13169openalex-snapshot

The performance of noninvasive indexes of adults in identification of nonalcoholic fatty liver disease in children

inferred← citeshttps://doi.org/10.1111/apt.16608openalex-snapshot

Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging

inferred← citeshttps://doi.org/10.1111/apt.16706openalex-snapshot

Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver

inferred← citeshttps://doi.org/10.1111/apt.70119openalex-snapshot

Afamin and Apolipoprotein F Associated With Liver Steatosis From People Living With HIV : A Discovery Study

inferred← citeshttps://doi.org/10.1111/nmo.13799openalex-snapshot

Ghrelin‐insulin‐like growth factor‐1 axis is activated via autonomic neural circuits in the non‐alcoholic fatty liver disease

inferred← citeshttps://doi.org/10.1126/scitranslmed.abe8939openalex-snapshot

Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors

inferred← citeshttps://doi.org/10.1136/bmjhci-2021-100510openalex-snapshot

Machine learning using longitudinal prescription and medical claims for the detection of non-alcoholic steatohepatitis (NASH)

inferred← citeshttps://doi.org/10.1155/2020/8822859openalex-snapshot

Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers

inferred← citeshttps://doi.org/10.1155/2021/6659445openalex-snapshot

Gegen Qinlian Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats via Oxidative Stress, Inflammation, and the NLRP3 Signal Axis

inferred← citeshttps://doi.org/10.1159/000531574openalex-snapshot

Hepatic Fibrosis Evaluated in Patients with Type 2 Diabetes with and without Chronic Kidney Disease

inferred← citeshttps://doi.org/10.11604/pamj.2020.37.270.9087openalex-snapshot

Cancer de la cavité orale chez trois frères germains en Mauritanie

inferred← citeshttps://doi.org/10.1177/1060028020935105openalex-snapshot

A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver Disease

inferred← citeshttps://doi.org/10.1242/dmm.048922openalex-snapshot

Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver

inferred← citeshttps://doi.org/10.12677/tcm.2025.1412761openalex-snapshot

Exploration of Research Progress on Traditional Chinese Medicine in Treating Metabolic-Associated Fatty Liver Disease Based on PINK1/Parkin-Mediated Mitophagy

inferred← citeshttps://doi.org/10.1371/journal.pcbi.1008735openalex-snapshot

From heterogeneous healthcare data to disease-specific biomarker networks: A hierarchical Bayesian network approach

inferred← citeshttps://doi.org/10.14218/jcth.2020.00015openalex-snapshot

A 3D Human Liver Model of Nonalcoholic Steatohepatitis

inferred← citeshttps://doi.org/10.14744/hf.2023.2023.0011openalex-snapshot

TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease

inferred← citeshttps://doi.org/10.14814/phy2.14795openalex-snapshot

ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis

inferred← citeshttps://doi.org/10.1515/biol-2022-0881openalex-snapshot

Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease

inferred← citeshttps://doi.org/10.1515/med-2021-0286openalex-snapshot

A nomogram for predicting metabolic steatohepatitis: The combination of NAMPT, RALGDS, GADD45B, FOSL2, RTP3, and RASD1

inferred← citeshttps://doi.org/10.15406/ghoa.2021.12.00469openalex-snapshot

An algorithm for the management of non-alcoholic fatty liver disease in primary care

inferred← citeshttps://doi.org/10.20944/preprints202307.1406.v1openalex-snapshot

The Role of C-reactive Protein in Aging associated NAFLD

inferred← citeshttps://doi.org/10.21203/rs.3.rs-841938/v1openalex-snapshot

Clitorin, a Flavonoid Compound of Papaya, Ameliorates Non-Alcoholic Fatty Liver Disease in Western Diet- induced Mice and Oleic Acid-induced HepG2 Cells

inferred← citeshttps://doi.org/10.21608/ejhm.2022.213807openalex-snapshot

Diagnostic Value of Portal Venous Pulsatility Index in Patients with High-Risk Nonalcoholic Fatty Liver Disease

inferred← citeshttps://doi.org/10.21608/ejhm.2022.229739openalex-snapshot

High Risk NAFLD among Patients with Irritable Bowel Syndrome: Frequency and Effect on Disease Severity

inferred← citeshttps://doi.org/10.21608/rpbs.2021.79353.1103openalex-snapshot

Anti-Diabetic Medications: A promising therapeutic approaches for the Management of NAFLD

inferred← citeshttps://doi.org/10.2174/1574885518666230417111247openalex-snapshot

Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver Disorder

inferred← citeshttps://doi.org/10.22141/2308-2097.59.2.2025.674openalex-snapshot

New approaches to diagnosis and management of patients with metabolic-associated steatotic liver disease with immune response to SARS-CоV-2

inferred← citeshttps://doi.org/10.25236/ijfm.2022.041005openalex-snapshot

Research Progress of Multi-Target Drugs in the Treatment of Non-Alcoholic Steatohepatitis

inferred← citeshttps://doi.org/10.30978/mg-2020-6-64openalex-snapshot

Non-alcoholic fatty liver disease: non-invasive markers and their importance in diagnosis

inferred← citeshttps://doi.org/10.33612/diss.180853744openalex-snapshot

Role of extracellular vesicles in hypoxia-induced hepatic injury in non-alcoholic fatty liver disease

inferred← citeshttps://doi.org/10.3389/fdgth.2026.1829881openalex-snapshot

Development of a machine learning model to identify individuals with VCTE-derived at-risk MASH in a Spanish Mediterranean region

inferred← citeshttps://doi.org/10.3389/fendo.2023.1230046openalex-snapshot

Lack of associations of microRNAs with severe NAFLD in people living with HIV: discovery case-control study

inferred← citeshttps://doi.org/10.3389/fimmu.2019.02852openalex-snapshot

Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases

inferred← citeshttps://doi.org/10.3389/fmed.2021.774079openalex-snapshot

MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis

inferred← citeshttps://doi.org/10.3389/fphar.2021.671640openalex-snapshot

Cellular Mechanisms of Liver Fibrosis

inferred← citeshttps://doi.org/10.3389/fpubh.2020.00220openalex-snapshot

Risk Prediction for Non-alcoholic Fatty Liver Disease Based on Biochemical and Dietary Variables in a Chinese Han Population

inferred← citeshttps://doi.org/10.3390/ani14152173openalex-snapshot

Establishment of a Steatosis Model in LMH Cells, Chicken Embryo Hepatocytes, and Liver Tissues Based on a Mixture of Sodium Oleate and Palmitic Acid

inferred← citeshttps://doi.org/10.3390/antiox10101529openalex-snapshot

Dimeric Histidine as a Novel Free Radical Scavenger Alleviates Non-Alcoholic Liver Injury

inferred← citeshttps://doi.org/10.3390/antiox8110524openalex-snapshot

White Peony (Fermented Camellia sinensis) Polyphenols Help Prevent Alcoholic Liver Injury via Antioxidation

inferred← citeshttps://doi.org/10.3390/biom10060898openalex-snapshot

Transcriptomically Revealed Oligo-Fucoidan Enhances the Immune System and Protects Hepatocytes via the ASGPR/STAT3/HNF4A Axis

inferred← citeshttps://doi.org/10.3390/biomedicines11102711openalex-snapshot

The Potential Role of C-Reactive Protein in Metabolic-Dysfunction-Associated Fatty Liver Disease and Aging

inferred← citeshttps://doi.org/10.3390/cancers13102305openalex-snapshot

Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease

inferred← citeshttps://doi.org/10.3390/cells9051105openalex-snapshot

Special Issue on “Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis”

inferred← citeshttps://doi.org/10.3390/cells9051237openalex-snapshot

Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH

inferred← citeshttps://doi.org/10.3390/cells9061346openalex-snapshot

Deletion of Perilipin 5 Protects against Hepatic Injury in Nonalcoholic Fatty Liver Disease via Missing Inflammasome Activation

inferred← citeshttps://doi.org/10.3390/cells9112457openalex-snapshot

Tissue-Resident Memory T Cells in the Liver—Unique Characteristics of Local Specialists

inferred← citeshttps://doi.org/10.3390/ijms231710072openalex-snapshot

Reversal of High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Metformin Combined with PGG, an Inducer of Glycine N-Methyltransferase

inferred← citeshttps://doi.org/10.3390/ijms26020564openalex-snapshot

Submicron Dispersions of Phytosterols Reverse Liver Steatosis with Higher Efficacy than Phytosterol Esters in a Diet Induced-Fatty Liver Murine Model

inferred← citeshttps://doi.org/10.3390/jcm11195969openalex-snapshot

Nonalcoholic Steatohepatitis: A 9-Year Follow Up Cohort Study

inferred← citeshttps://doi.org/10.3390/jcm14062054openalex-snapshot

MicroRNAs in the Diagnosis of Digestive Diseases: A Comprehensive Review

inferred← citeshttps://doi.org/10.3390/jcm14072441openalex-snapshot

Clinical and Economic Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Spanish Mediterranean Region: A Population-Based Study

inferred← citeshttps://doi.org/10.3390/jpm13050830openalex-snapshot

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease

inferred← citeshttps://doi.org/10.3390/microorganisms7110530openalex-snapshot

Isolation and Identification of Lactobacillus plantarum HFY05 from Natural Fermented Yak Yogurt and Its Effect on Alcoholic Liver Injury in Mice

inferred← citeshttps://doi.org/10.3390/nu13113679openalex-snapshot

Reduced Rank Regression-Derived Dietary Patterns Related to the Fatty Liver Index and Associations with Type 2 Diabetes Mellitus among Ghanaian Populations under Transition: The RODAM Study

inferred← citeshttps://doi.org/10.3390/nu14112187openalex-snapshot

The Role of Phytosterols in Nonalcoholic Fatty Liver Disease

inferred← citeshttps://doi.org/10.3390/nu15081960openalex-snapshot

Anti-Steatotic Effects of Chlorella vulgaris, Nannochloropsis gaditana and Gracilaria vermiculophylla Algae Extracts in AML-12 Hepatocytes

inferred← citeshttps://doi.org/10.3390/nu16142254openalex-snapshot

The Effect of Mobile Lifestyle Intervention Combined with High-Protein Meal Replacement on Liver Function in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Pilot Randomized Controlled Trial

inferred← citeshttps://doi.org/10.3390/nu17142367openalex-snapshot

Orchestrating Nutrient Homeostasis: RNA-Binding Proteins as Molecular Conductors in Metabolic Disease Pathogenesis

inferred← citeshttps://doi.org/10.36469/001c.123645openalex-snapshot

Artificial Intelligence in Identifying Patients With Undiagnosed Nonalcoholic Steatohepatitis

inferred← citeshttps://doi.org/10.36469/jheor.2024.123645openalex-snapshot

Artificial Intelligence in Identifying Patients With Undiagnosed Nonalcoholic Steatohepatitis

inferred← citeshttps://doi.org/10.37349/emed.2021.00066openalex-snapshot

Molecular targets regulating endoplasmic reticulum-mitochondria crosstalk for NAFLD treatment

inferred← citeshttps://doi.org/10.3748/wjg.v29.i28.4433openalex-snapshot

F-box only protein 2 exacerbates non-alcoholic fatty liver disease by targeting the hydroxyl CoA dehydrogenase alpha subunit

inferred← citeshttps://doi.org/10.3892/etm.2021.9965openalex-snapshot

Cytokines, paraoxonase‑1, periostin and non‑invasive liver fibrosis scores in patients with non‑alcoholic fatty liver disease and persistently elevated aminotransferases: A pilot study

inferred← citeshttps://doi.org/10.4103/injms.injms_194_25openalex-snapshot

Evaluation of Cytokeratin 18 and Fibroblast Growth Factor-21 as Noninvasive Biomarkers of Severity in Nonalcoholic Fatty Liver Disease

inferred← citeshttps://doi.org/10.47162/rjme.61.4.04openalex-snapshot

Pediatric nonalcoholic fatty liver disease – a changing diagnostic paradigm

inferred← citeshttps://doi.org/10.55788/723a4c4copenalex-snapshot

Comorbidity in adult psoriasis

inferred← citeshttps://doi.org/10.5772/intechopen.97568openalex-snapshot

Treatment of Nonalcoholic Fatty Liver Disease through Changes in Gut Microbiome and Intestinal Epithelial Barrier

inferred← citeshttps://doi.org/10.69860/nobel.9786053359111.7openalex-snapshot

Diabetes Mellitus and Non-alcoholic Fatty Liver Disease (NAFLD)

inferred← citeshttps://doi.org/10.70675/148e8289z1198z4813z9d5bz607270865048openalex-snapshot

NMR and UPLC-HRMS based Metabolomics : application in Non-alcoholic fatty liver disease and Prostate Cancer Biomarker Discovery

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.